Skip to main content
. 2015 Feb 4;30(6):768–776. doi: 10.1007/s11606-015-3202-0

Table 1.

Baseline Demographics*

Total population n = 771 Received hypertension diagnosis n = 315 Received antihypertensive medication n = 286
Patient characteristics
 Age, m (SD) 54 (14) 56 (14) 56 (14)
 Female 396 (51) 153 (49) 130 (45)
 Race/ethnicity
  White 643 (83) 260 (83) 235 (82)
  Non-white 128 (17) 55 (17) 51 (18)
 Marital status
  Married/Partnered 440 (57) 186 (59) 179 (63)
  Unmarried 331 (43) 129 (41) 107 (37)
  Medicaid, ever 110 (14) 43 (14) 40 (14)
 Tobacco use category
  Current tobacco use 349 (45) 143 (45) 133 (47)
  Non-smoker/former tobacco use 422 (55) 172 (55) 153 (54)
  Body mass index, kg/m2, m (SD) 34 (8.3) 34 (8.0) 34 (8.5)
 Primary spoken language
  English 712 (92) 299 (95) 273 (95)
  Other 59 (7.7) 16 (5.1) 13 (4.6)
 Stage of hypertension§
  Stage 1 639 (83) 245 (78) 224 (78)
  Stage 2 132 (17) 70 (22) 62 (22)
 Comorbidities
  Microvascular complications of diabetes 49 (6.4) 17 (5.4) 16 (5.6)
  Baseline dyslipidemia 377 (49) 154 (49) 141 (49)
  Atrial fibrillation 11 (1.4) 6 (1.9) 7 (2.5)
  Cerebrovascular disease with or without complications 19 (2.5) 5 (1.6) 6 (2.1)
  Peripheral vascular disease 31 (4.0) 7 (2.2) 6 (2.1)
  Depression 75 (9.7) 26 (8.3) 28 (9.8)
  Ischemic heart disease# 31 (4.0) 14 (4.4) 16 (5.6)
  Low prevalence indicator** 52 (6.7) 16 (5.1) 19 (6.6)
 Baseline ambulatory visit counts, annual, m (SD)
  Primary care visits 3.6 (3.1) 3.1 (2.5) 3.1 (2.6)
  Specialty care visits 2.8 (3.3) 2.3 (2.8) 2.2 (3.0)
  Urgent care visits 0.53 (1.1) 0.39 (0.89) 0.35 (0.82)
Provider characteristics††
  Female 337 (44) 143 (45) 125 (44)
 Specialty providing majority of ambulatory care
  Internal medicine 318 (41) 131 (42) 114 (40)
  Family medicine 375 (49) 154 (49) 141 (49)
  Other‡‡ 78 (10) 30 (9.5) 31 (11)
  Age, m (SD) 47 (10) 46 (10) 46 (10)

*Values represent numerators and percents unless otherwise specified. Diagnosis and treatment is based on 130/80 mmHg threshold

†Non-white ethnicities: African American (8.0 %); Hispanic/Latino (3.1 %); Asian (2.0 %); Native Hawaiian/Pacific Islander (0.9 %); American Indian/Alaska Native (0.1 %); Unknown (2.5 %)

‡On Medicaid during the baseline or study period

§Stage of hypertension is defined using JNC-7 criteria

An indicator variable was created for microvascular disease that consists of the presence of chronic kidney disease and/or eye disease

An indicator variable was created for cerebrovascular disease for the presence of any of the following co-morbidities: stroke, transient ischemic attack, or other neurologic condition

#An indicator variable was created for ischemic heart disease that consists of the presence of congestive heart failure and/or ischemic heart disease

**Due to low prevalence, an indicator variable was created for the presence of any of the following comorbidities: dementia, collagen vascular disease, malignancy

†† AMA is the source for the raw physician data (provider ages only); statistics, tables or tabulations were prepared by User-Customer (PI: H. Johnson) using AMA Masterfile data

‡‡ Other specialties: Pediatrics; obstetrics/gynecology; geriatrics